| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.44 | 0.003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.45 | 0.005 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |